mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.2 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |